FDA Tracker

FDA approvals, upcoming decision (PDUFA) dates, complete response letters and regulatory history for urology and GU oncology products.

Today's urology news · Urologic oncology · Subspecialties · Trainee Hub

Loading today's edition…

How items are ranked

Evidence level: regulatory action and guidelines, then phase 3 RCT, meta-analysis, prospective, retrospective, commentary.
Source tier: peer-reviewed journal and regulator first, then society and trade press.
Practice impact: whether it changes what a provider can offer this month.

Ranking is rule-based. No sponsor or author pays for placement.

Editorial policy

UrologyWatch is a neutral aggregator. Summaries are original and link to the primary source; we do not reproduce abstracts or figures. Items are selected and summarized with AI tools under rules the editors set, checked automatically against their sources and corrected when errors are found; they are not individually reviewed by a physician before publishing. How it works. A new edition is published every morning at about 5 AM ET.

Archive by date About UrologyWatch Urology History

Daily email

Not medical advice

Content is for general information. Patients should discuss any treatment decision with their own urology provider.

Privacy Terms of use